April 21 Embattled Canadian drugmaker Valeant
Pharmaceuticals International Inc, said on
Friday that it had priced its recently approved plaque psoriasis
treatment at $3,500 per month.
The drug, Siliq, is the lowest priced injectable biologic
psoriasis treatment currently on the market, Valeant said.
The company expects to launch the drug in the United States
in the second half of 2017.
The drug secured U.S. Food and Drug Administration approval
in February this year.
(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by